Keywords: scotland, pfizer, sutent, scottish, medicines, consortium, ruled

Scotland "no" to Pfizer's Sutent

Article | 30 October 2006

Print This

The Scottish Medicines Consortium has ruled against the funding of Pfizer's new cancer drug Sutent (sunitinib), for the second-line treatment ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in